Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JetBlue Airways Corporation (JBLU) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance

JetBlue Airways CorporationTrade
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)Trade

Price performance (Past 24H)

Key statistics

JetBlue Airways Corporation vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? JetBlue Airways Corporation trades at $3.02 (market cap $1.26B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $38.05 (market cap $63.57B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 50.5× JetBlue Airways Corporation's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.49% dividend while JetBlue Airways Corporation pays none. Which is the better fit depends on your goals.

JBLURELX
Market Cap
$1.26B$63.57B
Volume
40,642,5251,602,093
Sector
IndustrialsIndustrials
52-Week High
$6.46$46.80
52-Week Low
$3.01$27.73
Typical Hold Time
44 Days—
Enterprise Value
$8.63B$75.05B
Dividend Yield
—2.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JetBlue Airways Corporation

JetBlue (JBLU) trades at $3.01, down 16.85% in the last 24 hours, reflecting significant bearish pressure. The stock exhibits weak fundamentals with a negative net income margin of -9.32% and consecutive quarterly losses, though it beat EPS expectations in Q2 2026. Technical indicators are predominantly bearish, with the stock trading near key support levels. Recent news highlights expansion efforts like new routes to Colombia and the launch of BlueFirst premium seating, aiming to boost revenue amid industry challenges.

The outlook remains challenging due to persistent losses, high debt levels, and elevated fuel costs. While analyst consensus suggests a hold rating with a $5.89 price target implying potential upside, risks from competitive pressures and macroeconomic factors dominate. Investment appeal is limited to speculative positions betting on a operational turnaround despite current headwinds.

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.

The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JBLU
91% Buy9% Sell
Avg holding period · 44 Days
RELX

No sentiment data available yet.

About JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.

Read more on JBLU →

About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.

Read more on RELX →